NCT00259766已完成3 期
Symbicort and Health Economics in a Real Life Evaluation - SHARE - A Randomised, Open-Label, Parallel-Group, Multicentre Study to Assess the Asthma-Related Health-Care Costs, in Ordinary Clinical Practice During 12 Months
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,970
- 试验地点
- 108
- 主要终点
- Asthma-related health-care utilization as measured by total amount of asthma medication purchased and number of contacts with health-care facilities
研究概览
简要总结
The purpose of this study is to compare health-related costs and asthma control in ordinary clinical practice during 12 months for Symbicort® given as a low maintenance dose plus as needed compared to a free combination of Pulmicortâ and Oxis® plus Bricanyl® as needed, and Symbicort fixed dosing plus Bricanyl as needed in asthmatic patients not adequately controlled on inhaled glucocorticosteroids alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 12 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed informed consent,
- •previously treated with glucocorticosteroids and B2-agonist
排除标准
- •History of smoking, pregnancy, any significant disease or disorder which may put the patient at risk because of study participation
结局指标
主要结局
Asthma-related health-care utilization as measured by total amount of asthma medication purchased and number of contacts with health-care facilities
次要结局
- Number of days patients or assistant persons are absent from work due to patient's asthma
- Number of exacerbations and treatment failures
研究者
研究点 (108)
Loading locations...
相似试验
已完成
不适用
Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US StudyAsthmaNCT01287351Research in Real-Life Ltd82,903
已完成
不适用
Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination TherapyAsthmaNCT01697722Research in Real-Life Ltd815,377
已完成
不适用
Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled CorticosteroidsAsthmaNCT01332344GlaxoSmithKline5,180
已完成
3 期
Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyAsthmaNCT00319306AstraZeneca550
已完成
不适用
Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPDChronic Obstructive Pulmonary DiseaseNCT01141452Research in Real-Life Ltd815,377
